Ngā hua rapu - CL Gaich
- E whakaatu ana i te 1 - 5 hua o te 5
-
1
-
2
Long-Term work Productivity improvement from Phase 3 Baricitinib Ra-Beam Study: Latin American Subgroup Analysis mā M. Papadimitropoulos, JR Gonzaga, Laíse Margarida Malcher Lopes Gonçalves, P Martínez-Osuna, Baojin Zhu, CL Gaich, EG Garcia
I whakaputaina 2017Artigo -
3
Characteristics of Latin American Patients With Rheumatoid Arthritis Receiving Advanced Therapy mā Allen Brnabic, Ricardo Machado Xavier, Laíse Margarida Malcher Lopes Gonçalves, James Lucas, Paul Hernandez, CL Gaich, M. Papadimitropoulos
I whakaputaina 2017Artigo -
4
-
5
Patient-Reported outcomes from Phase 3 Baricitinib Ra-Begin Study: Latin American Subgroup Analysis mā M. Papadimitropoulos, Cristiano A. F. Zerbini, Cesar Ramos‐Remus, P Martínez-Osuna, Baojin Zhu, CL Gaich, EG Garcia, LF Golcalves
I whakaputaina 2017Artigo
Ngā utauta rapu:
Ngā marau whai pānga
Internal medicine
Medicine
Rheumatoid arthritis
Physical therapy
Methotrexate
Alternative medicine
Confidence interval
Nursing
Pathology
Placebo
Quality of life (healthcare)
Subgroup analysis
Visual analogue scale
Adalimumab
Burden of disease
Categorical variable
Combination therapy
Computer science
Continuous variable
Demographics
Demography
Diabetes mellitus
Disease
Economics
Endocrinology
Gerontology
Imputation (statistics)
Latin Americans
Law
Linguistics